Latest Articles
AKR1B1 and AKR1B10 as prognostic markers in endometrial cancer - BioWorld MedTech
AKR1B1 and AKR1B10 as prognostic markers in endometrial cancer BioWorld MedTech
Published: Oct. 17, 2025, 1 p.m.
(PDF) Endometrial receptivity profiled through transcriptomic analysis of uterine fluid extracellular vesicles using systems biology and bayesian modeling for pregnancy prediction - researchgate.net
(PDF) Endometrial receptivity profiled through transcriptomic analysis of uterine fluid extracellular vesicles using systems biology and bayesian modeling for pregnancy prediction researchgate.net
Published: Oct. 17, 2025, 3:50 a.m.
Th1 and Th2 cells in equine endometrosis and their interactions with endometrial fibroblasts - Nature
Th1 and Th2 cells in equine endometrosis and their interactions with endometrial fibroblasts Nature
Published: Oct. 16, 2025, 2:56 p.m.
Metastatic endometrial stromal sarcoma with sex cord and neuroendocrine differentiation harboring a complex gene fusion - BioMed Central
Metastatic endometrial stromal sarcoma with sex cord and neuroendocrine differentiation harboring a complex gene fusion BioMed Central
Published: Oct. 16, 2025, 2:22 p.m.
Long-Term Benefit of Adjuvant Therapy for Endometrial Cancer Patients - Labroots
Long-Term Benefit of Adjuvant Therapy for Endometrial Cancer Patients Labroots
Published: Oct. 16, 2025, 10 a.m.
Circulating biomarkers of infection and endometrial cancer risk - springermedicine.com
Circulating biomarkers of infection and endometrial cancer risk springermedicine.com
Published: Oct. 16, 2025, 2:26 a.m.
Diagnostic dilemma in post-abortion intrauterine retention: endometrial polyps mimicking retained products of conception - Frontiers
Diagnostic dilemma in post-abortion intrauterine retention: endometrial polyps mimicking retained products of conception Frontiers
Published: Oct. 16, 2025, 12:47 a.m.
Dr Pillay: Endometrial cancer on the rise - The Fiji Times
Dr Pillay: Endometrial cancer on the rise The Fiji Times
Published: Oct. 16, 2025, 12:31 a.m.
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer OncLive
Published: Oct. 15, 2025, 5:46 p.m.
Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer - OncLive
Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer OncLive
Published: Oct. 15, 2025, 12:10 p.m.
Link copied to clipboard!